LEADER 01860nam  2200553 a 450 
001 9910455935203321
005 20200520144314.0
010   $a1-280-24686-3
010   $a9786610246861
010   $a0-309-58520-1
010   $a0-585-08550-1
035   $a(CKB)110986584751250
035   $a(SSID)ssj0000156460
035   $a(PQKBManifestationID)11160004
035   $a(PQKBTitleCode)TC0000156460
035   $a(PQKBWorkID)10129452
035   $a(PQKB)11247446
035   $a(MiAaPQ)EBC3376294
035   $a(Au-PeEL)EBL3376294
035   $a(CaPaEBR)ebr10055382
035   $a(CaONFJC)MIL24686
035   $a(OCoLC)923262665
035   $a(EXLCZ)99110986584751250
100   $a19930311d1992      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aFood and Drug Administration advisory committees$b[electronic resource] /$fCommittee to Study the Use of Advisory Committees by the Food and Drug Administration ; Richard A. Rettig, Laurence E. Earley, Richard A. Merrill, editors
210   $aWashington, D.C. $cNational Academy Press$d1992
215   $axii, 226 p. $cill
300   $a"Division of Health Care [sic] Policy, Institute of Medicine."
311   $a0-309-04837-0 
320   $aIncludes bibliographical references.
606   $aPublic health advisory groups$zUnited States$xEvaluation
608   $aElectronic books.
615  0$aPublic health advisory groups$xEvaluation.
676   $a353.0077/8
701   $aRettig$b Richard A$0869711
701   $aEarley$b Laurence E$0899733
701   $aMerrill$b Richard A$0100299
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910455935203321
996   $aFood and Drug Administration advisory committees$92010318
997   $aUNINA